butyric acid has been researched along with Diabetic Nephropathies in 6 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, K | 1 |
| Ma, Y | 1 |
| Cai, F | 1 |
| Huang, X | 1 |
| Xiao, L | 1 |
| Zhong, C | 1 |
| Ren, P | 1 |
| Luo, Q | 1 |
| Chen, J | 1 |
| Han, F | 1 |
| Zhou, T | 1 |
| Xu, H | 1 |
| Cheng, X | 1 |
| He, Y | 1 |
| Ren, Q | 1 |
| Li, D | 1 |
| Xie, Y | 1 |
| Gao, C | 1 |
| Zhang, Y | 1 |
| Sun, X | 1 |
| Xu, Y | 1 |
| Huang, W | 2 |
| Yan, M | 1 |
| Zhang, YY | 1 |
| Xi, Y | 1 |
| Ding, LK | 1 |
| Sun, C | 1 |
| Qu, LJ | 1 |
| Qian, X | 1 |
| Xu, JW | 1 |
| Sun, W | 2 |
| Wu, L | 1 |
| Du, Y | 1 |
| Tang, G | 1 |
| Yuan, W | 1 |
| Yang, H | 1 |
| Zhang, Z | 1 |
| Peng, R | 1 |
| Zhang, L | 1 |
| Liu, H | 1 |
| Wang, X | 1 |
| Tian, Y | 1 |
| Sun, Y | 1 |
| Dong, W | 1 |
| Jia, Y | 1 |
| Liu, X | 1 |
| Zhang, H | 1 |
| Li, T | 1 |
| Chen, X | 1 |
| Wang, F | 1 |
| Wu, H | 1 |
6 other studies available for butyric acid and Diabetic Nephropathies
| Article | Year |
|---|---|
Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
Topics: AMP-Activated Protein Kinases; Animals; Butyric Acid; Diabetes Mellitus; Diabetic Nephropathies; Fat | 2022 |
Sodium Butyrate Attenuates Diabetic Kidney Disease Partially via Histone Butyrylation Modification.
Topics: Butyric Acid; Diabetes Mellitus; Diabetic Nephropathies; Histones; Humans; Inflammation; Protein Pro | 2022 |
Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice.
Topics: Animals; Butyric Acid; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Humans; Hyp | 2023 |
Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db/db mice and HG‑induced NRK‑52E cells.
Topics: Animals; Apoptosis; Butyric Acid; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Gene Ex | 2020 |
RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models.
Topics: Animals; Butyric Acid; Diabetic Nephropathies; Male; Mice; RNA, Long Noncoding; RNA, Messenger; Tran | 2021 |
Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
Topics: Animals; Apoptosis; Butyric Acid; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Histone D | 2017 |